The fact that a diagnosis of diabetes < 5 years prior to the study was the strongest predictor of HbA1c reduction further highlights the need for an early proactive intervention, when beta-cell function and insulin resistance are still adjustable. This evidence concerns the gene INS and diabetes mellitus.